TC
Toucan Capital
Venture CapitalModerateToucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology
8
Investments
2
Exits
—
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Toucan Capital.
Investment Thesis & Strategy
Toucan Capital invests in seed and early-stage biotech, life science, and healthcare companies, with a focus on advanced technology. They typically invest in companies with high growth potential.
Investment Activity
Deals per year over the last 6 years
4
20181
20194
20200
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 8 companies
A
Aegle Therapeutics
Biotech · Series B, 2023
I
InnoLife
Biotech · Series B, 2022
C
Cerebral Therapeutics
Biotech · Growth, 2022
C
Cerebral Therapeutics
Biotech · Series B, 2020
I
InnoLife
Biotech · Series A, 2020
K
Keros Therapeutics
Biotech · Growth, 2020
A
Aegle Therapeutics
Biotech · Series A, 2020
K
Keros Therapeutics
Biotech · Series B, 2019
V
Vaxart
Biotech · Growth, 2018
C
Cerebral Therapeutics
Biotech · Series A, 2018
I
InnoLife
Biotech · Seed, 2018
A
Aegle Therapeutics
Biotech · Seed, 2018
Frequently Asked Questions
Toucan Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Novak Biddle Venture Partners
Bethesda, United States · 117 deals
CNF Investments, LLC
Bethesda, United States · 45 deals
Northpond Ventures
Bethesda, United States · 32 deals
American Capital
Bethesda, United States · 31 deals
MicroVest
Bethesda, United States · 12 deals
Calvert Social Venture Partners
Bethesda, United States · 12 deals